Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.2000 (1.28%) ($14.2000 - $14.2000) on Mon. Aug. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.83% (three month average) | RSI | 69 | Latest Price | $14.2000(1.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 5.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 6.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(32%) VUG(30%) XLK(30%) VT(29%) URA(28%) | Factors Impacting BCRX price | BCRX will decline at least -2.415% in a week (0% probabilities). UUP(-15%) VIXM(-13%) SMH(-8%) EDOC(-5%) VXX(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.415% (StdDev 4.83%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.81(10.85%) | 10 Day Moving Average | $11.95(18.83%) | 20 Day Moving Average | $11.72(21.16%) | To recent high | 0% | To recent low | 81.1% | Market Cap | $2.505b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |